Pfizer Ireland Pharmaceuticals
Records under this name other than the patents Pfizer Ireland Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Pfizer Ireland Pharmaceuticals
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,388,167 | Process for the Preparation of Voriconazole and Analogues Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,499,520 | Process for the Preparation of Voriconazole and Analogues Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,683,998 | Tumor Necrosis Factor-Like Ligand 1A Specific Antibodies and Compositions and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,202,438 | Synthetic Library of Specific Binding Molecules Formerly held In force · High confidence | In force | High confidence | |
| US 10,472,410 | Isolation of Therapeutic Target Specific Vnar Domains to Icosl Formerly held In force · High confidence | In force | High confidence | |
| US 10,544,212 | ANTI-IL-33 Antibodies, Compositions, Methods and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,083,724 | Rimegepant for CGRP Related Disorders Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,566,066 | ANTI-GDF15 Antibodies, Compositions and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 12,410,145 | Efficient Process For Making 6-Carboxy Benzoxazole Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 6,248,570 | Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines Term ended Term ended Dec 23, 2018 · USPTO record | Term ended | Term ended Dec 23, 2018 | USPTO record |